[HTML][HTML] SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020–March 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated
because of limited access to testing. We measured SARS-CoV-2 seroprevalence in …
because of limited access to testing. We measured SARS-CoV-2 seroprevalence in …
[HTML][HTML] SARS-CoV-2 seroprevalence after third wave of infections, South Africa
By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2
infections in South Africa, seroprevalence was 60% in a rural community and 70% in an …
infections in South Africa, seroprevalence was 60% in a rural community and 70% in an …
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From Adult Index Cases With and Without Human Immunodeficiency Virus in South …
…, S Walaza, NA Martinson, M Neti… - Clinical Infectious …, 2023 - academic.oup.com
Background In South Africa, 19% of adults are living with human immunodeficiency virus (HIV;
LWH). Few data on the influence of HIV on severe acute respiratory syndrome …
LWH). Few data on the influence of HIV on severe acute respiratory syndrome …
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Background SARS-CoV-2 infections may be underestimated due to limited testing access,
particularly in sub-Saharan Africa. South Africa experienced two SARS-CoV-2 waves, the …
particularly in sub-Saharan Africa. South Africa experienced two SARS-CoV-2 waves, the …
Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational …
J Kleynhans, S Walaza, NA Martinson, M Neti… - medRxiv, 2022 - medrxiv.org
Background In South Africa 19% of the adult population aged 15-49 years are living with
HIV (LWH). Few data on the influence of HIV on SARS-CoV-2 household transmission are …
HIV (LWH). Few data on the influence of HIV on SARS-CoV-2 household transmission are …
SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, after the third wave, April-November 2021
By November 2021, after the third SARS-CoV-2 wave in South Africa, seroprevalence was
60% (95%CrI 56%-64%) in a rural and 70% (95%CrI 56%-64%) in an urban community; …
60% (95%CrI 56%-64%) in a rural and 70% (95%CrI 56%-64%) in an urban community; …
[HTML][HTML] A descriptive study of a SARS-CoV-2 super spreader event: A funeral and a house-party in a district municipality of the Eastern Cape Province, South Africa …
…, N Mini, L Ngcwangu, M Neti… - … and Public Health, 2022 - afenet-journal.net
Introduction: Coronavirus Disease 2019 (COVID-19) is a respiratory illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health …
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
A new SARS-CoV-2 variant of concern, Omicron (B.1.1.529), has been identified based on
genomic sequencing and epidemiological data in South Africa. Presumptive Omicron cases …
genomic sequencing and epidemiological data in South Africa. Presumptive Omicron cases …
[HTML][HTML] Population immunity and Covid-19 severity with Omicron variant in South Africa
Background The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South …
2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South …
South African population immunity and severe Covid-19 with omicron variant
Background We conducted a seroepidemiological survey from October 22 to December 9,
2021, in Gauteng Province, South Africa, to determine SARS-CoV-2 immunoglobulin G (IgG) …
2021, in Gauteng Province, South Africa, to determine SARS-CoV-2 immunoglobulin G (IgG) …